WeVote
Log In

Bill

Bill

LD 1078

An Act To Support Maine'S Public Health Objectives By Increasing Access To Hypodermic Apparatus Exchange Programs

132nd Legislature (2025-2026) Introduced by Mark Babin and 7 co-sponsors

Authorizes expanded locations for certified syringe exchange programs within the same county to increase access, disposal, testing, and referrals.

Became Law without Governor's Signature
#substanceusedisorder #syringedisposalservices #treatment
0
WeVote Research Nonpartisan
Bill Summary · LD 1078

Summary — LD 1078 (132nd Maine Legislature)

Title: An Act To Support Maine's Public Health Objectives By Increasing Access To Hypodermic Apparatus Exchange Programs
Status: Became law without the Governor’s signature (June 22, 2025)
Introduced: March 14, 2025
Subject areas: Substance use disorder, syringe disposal services, treatment

Purpose / Intent

LD 1078 is intended to expand access to hypodermic apparatus (syringe) exchange services as a public‑health intervention—reducing the spread of bloodborne infections, increasing safe syringe disposal, and creating better bridge points to medical and treatment services for people who inject drugs.

Key provisions (as reflected in available documents)

  • Authorizes expanded operation of certified hypodermic apparatus exchange programs by permitting additional program locations in the same county as a location already authorized under the program’s certification.
  • Implements the expansion through amendments adopted as Committee Amendment “A” (H‑485); that amendment was incorporated into the final engrossed bill.

(The bill text itself is not reproduced here; the above description is based on the legislative and fiscal documents associated with LD 1078.)

Who is affected

  • Certified hypodermic apparatus exchange programs operating in Maine (they gain statutory authority to add locations within the same county).
  • People who inject drugs and communities affected by injection‑related disease and improper syringe disposal (may benefit from increased access to sterile equipment, disposal, testing, and referrals).
  • Department of Health and Human Services and local public‑health entities (administrative/oversight role).
  • Potentially local governments, public health providers, harm‑reduction organizations, and law enforcement insofar as service locations and disposal practices change.

Fiscal impact

  • Preliminary fiscal note (approved 04/01/25 for the original bill) estimated an ongoing General Fund cost of $426,668 annually beginning FY 2025‑26 to the Department of Health and Human Services to fund operation of additional locations.
  • Subsequent fiscal notes for the bill as amended (approved 05/27/25 and 06/09/25) indicate NO FISCAL IMPACT for the amended/engrossed versions (LR 2234(02) and LR 2234(03)).
  • Net effect: the original bill as filed carried an estimated state cost; the final enacted form (with Committee Amendment A) was determined to impose no additional state fiscal obligation.

Legislative history / timeline (highlights)

  • 2025‑03‑14: Bill received and referred to the Committee on Health and Human Services.
  • 2025‑05‑16: Work session; divided report.
  • 2025‑06‑05: House passed as amended (Vote: Yeas 74 – Nays 65). Committee Amendment A (H‑485) adopted.
  • 2025‑06‑09: Senate accepted Majority Ought to Pass as Amended; roll call 20–11. Committee Amendment A read and adopted.
  • 2025‑06‑22: Became law without the Governor’s signature.

Practical effect and considerations

  • The enacted law removes or reduces statutory barriers that limited the geographic placement of additional exchange sites by certified programs within the same county, making it administratively easier to expand service points.
  • Increased access to syringe exchange services is associated (in public‑health literature) with reductions in transmission of HIV/HCV, improved safe disposal, and increased linkage to treatment and social services.
  • With final fiscal notes showing no state cost, expansions under the law may be carried out by existing programs using their resources or external funding (grants, local funding, federal/private support) rather than new recurring state appropriations.

If you would like, I can locate and summarize the final enrolled bill text (including the exact statutory language added or amended), or compile research on implementation practices and funding options for syringe exchange programs.

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.